UPL Q1 FY27 results (Apr–Jun 2026) and concall

Chemicals · Concall AI · Call held 3 Aug 2026

Company page: UPL share price, financials & guidance record

UPL Limited delivered a resilient Q1 FY27 performance, achieving its seventh consecutive quarter of revenue and EBITDA growth with a 10% increase in revenue to ₹10,181 crores and a 15% rise in EBITDA to ₹1,500 crores. PATMI turned positive for the first time in three years. Despite macroeconomic headwinds like geopolitical uncertainties and adverse weather impacting volumes, strategic pricing actions and strong performance in Seeds and Super Specialty Chemicals contributed to growth. The company also made progress on deleveraging, reducing gross debt and improving its net debt-to-EBITDA ratio.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 10.5%, net profit up 58.5% against the same quarter last year.

₹ Cr · quarterly

Line item	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	10,907	15,573	9,216	12,019	12,269 +12%	18,335 +18%	10,181 +10%
Expenses	9,229	12,409	7,820	10,072	10,033	14,854	8,814
EBITDA	1,678	3,164	1,396	1,947	2,236 +33%	3,481 +10%	1,367 −2%
Margin	15%	20%	15%	16%	18%	19%	13%
Other income	94	-168	152	392	36	162	208
Interest	730	914	1,007	784	774	836	852
Depreciation	688	705	731	771	827	915	832
Profit before tax	354	1,377	-190	784	671 +90%	1,892 +37%	-109 +43%
Tax rate	-141%	22%	-7%	22%	27%	32%	-33%
Net profit	853	1,079	-176	612	490 −43%	1,294 +20%	-73 +59%
EPS	10.58	11.45	-1.12	6.56	4.70	12.57	0.12

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Chemicals earnings calls